AST(SGOT)/ALT(SGPT 0 18 0 18 B-clinical_variable
) 18 19 18 19 I-clinical_variable
less 20 24 20 24 O
than 25 29 25 29 O
or 30 32 30 32 O
equal 33 38 33 38 O
to 39 41 39 41 O
3.0 42 45 42 45 B-upper_bound
times 46 51 46 51 I-upper_bound
institutional 52 65 52 65 I-upper_bound
upper 66 71 66 71 I-upper_bound
limit 72 77 72 77 I-upper_bound
of 78 80 78 80 I-upper_bound
normal 81 87 81 87 I-upper_bound

Abnormal 0 8 88 96 B-clinical_variable
PC 9 11 97 99 I-clinical_variable
immunophenotype 12 27 100 115 I-clinical_variable
( 28 29 116 117 O
greater 29 36 117 124 O
than 37 41 125 129 O
or 42 44 130 132 O
equal 45 50 133 138 O
to 51 53 139 141 O
95 54 56 142 144 B-lower_bound
% 56 57 144 145 I-lower_bound
of 58 60 146 148 O
BMPCs 61 66 149 154 O
are 67 70 155 158 O
clonal 71 77 159 165 O
) 77 78 165 166 O

Absence 0 7 167 174 O
of 8 10 175 177 O
anemia 11 17 178 184 B-chronic_disease

Absence 0 7 185 192 O
of 8 10 193 195 O
hypercalcemia 11 24 196 209 B-chronic_disease

Absence 0 7 210 217 O
of 8 10 218 220 O
lytic 11 16 221 226 O
bone 17 21 227 231 O
lesion 22 28 232 238 O
on 29 31 239 241 O
X 32 33 242 243 O
- 33 34 243 244 O
ray 34 37 244 247 O
, 37 38 247 248 O
CT 39 41 249 251 O
, 41 42 251 252 O
or 43 45 253 255 O
PET 46 49 256 259 O
/ 49 50 259 260 O
CT 50 52 260 262 O
and 53 56 263 266 O
not 57 60 267 270 O
more 61 65 271 275 O
than 66 70 276 280 O
1 71 72 281 282 B-lower_bound
lesion 73 79 283 289 O
on 80 82 290 292 O
spinal 83 89 293 299 B-treatment
MRI 90 93 300 303 I-treatment

Absence 0 7 304 311 O
of 8 10 312 314 O
renal 11 16 315 320 B-chronic_disease
failure 17 24 321 328 I-chronic_disease

Active 0 6 329 335 O
hepatitis 7 16 336 345 B-chronic_disease
B 17 18 346 347 I-chronic_disease
or 19 21 348 350 I-chronic_disease
C 22 23 351 352 I-chronic_disease
infection 24 33 353 362 I-chronic_disease

Age 0 3 363 366 B-age
greater 4 11 367 374 O
than 12 16 375 379 O
or 17 19 380 382 O
equal 20 25 383 388 O
to 26 28 389 391 O
18 29 31 392 394 B-lower_bound
years 32 37 395 400 I-lower_bound

Breastfeeding 0 13 401 414 O
women 14 19 415 420 B-gender
and 20 23 421 424 O
women 24 29 425 430 O
planning 30 38 431 439 O
on 39 41 440 442 O
breastfeeding 42 55 443 456 O
may 56 59 457 460 O
not 60 63 461 464 O
participate 64 75 465 476 O

Ca 0 2 477 479 B-clinical_variable
< 3 4 480 481 O
10.5 4 8 481 485 B-upper_bound
mg 9 11 486 488 I-upper_bound
/ 11 12 488 489 I-upper_bound
dl 12 14 489 491 I-upper_bound

Clonal 0 6 492 498 B-clinical_variable
BMPCs 7 12 499 504 I-clinical_variable
50%-60 13 19 505 511 B-lower_bound
% 19 20 511 512 I-upper_bound

Concurrent 0 10 513 523 O
systemic 11 19 524 532 B-treatment
treatment 20 29 533 542 I-treatment
or 30 32 543 545 O
prior 33 38 546 551 B-treatment
therapy 39 46 552 559 I-treatment
within 47 53 560 566 O
4 54 55 567 568 B-upper_bound
weeks 56 61 569 574 I-upper_bound
for 62 65 575 578 O
SMM 66 69 579 582 B-cancer

Contraindication 0 16 583 599 O
to 17 19 600 602 O
any 20 23 603 606 O
concomitant 24 35 607 618 O
medication 36 46 619 629 B-treatment
, 46 47 629 630 O
including 48 57 631 640 O
antivirals 58 68 641 651 B-treatment
, 68 69 651 652 O
anticoagulation 70 85 653 668 B-treatment
prophylaxis 86 97 669 680 I-treatment
, 97 98 680 681 O
tumor 99 104 682 687 B-treatment
lysis 105 110 688 693 I-treatment
prophylaxis 111 122 694 705 I-treatment
, 122 123 705 706 O
or 124 126 707 709 O
hydration 127 136 710 719 B-treatment
given 137 142 720 725 O
prior 143 148 726 731 O
to 149 151 732 734 O
therapy 152 159 735 742 B-treatment

CrCl 0 4 743 747 B-clinical_variable
( 5 6 748 749 O
calculated 6 16 749 759 O
) 16 17 759 760 O
= 18 19 761 762 O
( 20 21 763 764 O
140 21 24 764 767 O
Age 25 28 768 771 B-age
) 28 29 771 772 O
times 30 35 773 778 O
Mass 36 40 779 783 O
( 41 42 784 785 O
in 42 44 785 787 O
kilograms 45 54 788 797 O
) 54 55 797 798 O

CrCl 0 4 799 803 B-clinical_variable
will 5 9 804 808 O
be 10 12 809 811 O
calculated 13 23 812 822 O
by 24 26 823 825 O
Cockcroft 27 36 826 835 O
Gault 37 42 836 841 O
method 43 49 842 848 O

Creatinine 0 10 849 859 B-clinical_variable
Clearance 11 20 860 869 I-clinical_variable
greater 21 28 870 877 O
than 29 33 878 882 O
or 34 36 883 885 O
equal 37 42 886 891 O
to 43 45 892 894 O
60 46 48 895 897 B-lower_bound
ml 49 51 898 900 I-lower_bound
/ 51 52 900 901 I-lower_bound
min 52 55 901 904 I-lower_bound

ECOG 0 4 905 909 B-clinical_variable
performance 5 16 910 921 I-clinical_variable
status 17 23 922 928 I-clinical_variable
less 24 28 929 933 O
than 29 33 934 938 O
or 34 36 939 941 O
equal 37 42 942 947 O
to 43 45 948 950 O
2 46 47 951 952 B-upper_bound
( 48 49 953 954 O
Karnofsky 49 58 954 963 B-clinical_variable
greater 59 66 964 971 O
than 67 71 972 976 O
or 72 74 977 979 O
equal 75 80 980 985 O
to 81 83 986 988 O
60 84 86 989 991 B-lower_bound
% 86 87 991 992 I-lower_bound
) 87 88 992 993 O

Has 0 3 994 997 O
refractory 4 14 998 1008 O
GI 15 17 1009 1011 B-chronic_disease
disease 18 25 1012 1019 I-chronic_disease
with 26 30 1020 1024 O
refractory 31 41 1025 1035 O
nausea 42 48 1036 1042 O
/ 48 49 1042 1043 O
vomiting 49 57 1043 1051 O
, 57 58 1051 1052 O
inflammatory 59 71 1053 1065 B-chronic_disease
bowel 72 77 1066 1071 I-chronic_disease
disease 78 85 1072 1079 I-chronic_disease
, 85 86 1079 1080 O
or 87 89 1081 1083 O
bowel 90 95 1084 1089 B-treatment
resection 96 105 1090 1099 I-treatment
that 106 110 1100 1104 O
would 111 116 1105 1110 O
prevent 117 124 1111 1118 O
absorption 125 135 1119 1129 O

Hemoglobin 0 10 1130 1140 B-clinical_variable
> 11 12 1141 1142 O
10 12 14 1142 1144 B-lower_bound
g 15 16 1145 1146 I-lower_bound
/ 16 17 1146 1147 I-lower_bound
dl 17 19 1147 1149 I-lower_bound

History 0 7 1150 1157 O
of 8 10 1158 1160 O
allergic 11 19 1161 1169 O
reactions 20 29 1170 1179 O
attributed 30 40 1180 1190 O
to 41 43 1191 1193 O
compounds 44 53 1194 1203 O
of 54 56 1204 1206 O
similar 57 64 1207 1214 O
chemical 65 73 1215 1223 O
or 74 76 1224 1226 O
biologic 77 85 1227 1235 O
composition 86 97 1236 1247 O
to 98 100 1248 1250 O
carfilzomib 101 112 1251 1262 B-treatment
or 113 115 1263 1265 O
lenalidomide 116 128 1266 1278 B-treatment
agents 129 135 1279 1285 O
used 136 140 1286 1290 O
in 141 143 1291 1293 O
study 144 149 1294 1299 O
, 149 150 1299 1300 O
such 151 155 1301 1305 O
as 156 158 1306 1308 O
bortezomib 159 169 1309 1319 B-treatment
or 170 172 1320 1322 O
thalidomide 173 184 1323 1334 B-treatment
, 184 185 1334 1335 O
in 186 188 1336 1338 O
addition 189 197 1339 1347 O
to 198 200 1348 1350 O
patients 201 209 1351 1359 O
with 210 214 1360 1364 O
known 215 220 1365 1370 O
allergy 221 228 1371 1378 O
to 229 231 1379 1381 O
sulfobutyl 232 242 1382 1392 B-allergy_name
ether 243 248 1393 1398 O
< 249 250 1399 1400 O
= 250 251 1400 1401 O
- 251 252 1401 1402 O
cyclodextrin 253 265 1403 1415 B-allergy_name
( 266 267 1416 1417 O
Captisol 267 275 1417 1425 O
) 276 277 1426 1427 O

IgA 0 3 1428 1431 O
SMM 4 7 1432 1435 B-cancer

Immunoparesis 0 13 1436 1449 B-treatment
with 14 18 1450 1454 O
reduction 19 28 1455 1464 O
of 29 31 1465 1467 O
2 32 33 1468 1469 O
uninvolved 34 44 1470 1480 O
immunoglobulin 45 59 1481 1495 B-clinical_variable
isotypes 60 68 1496 1504 I-clinical_variable

Involved 0 8 1505 1513 O
- 8 9 1513 1514 O
un 9 11 1514 1516 O
- 11 12 1516 1517 O
involved 12 20 1517 1525 O
light 21 26 1526 1531 B-clinical_variable
chain 27 32 1532 1537 I-clinical_variable
ratio 33 38 1538 1543 I-clinical_variable
must 39 43 1544 1548 O
be 44 46 1549 1551 O
< 47 48 1552 1553 O
100 48 51 1553 1556 B-upper_bound

Lenalidomide 0 12 1557 1569 B-treatment
is 13 15 1570 1572 O
teratogenic 16 27 1573 1584 B-treatment
with 28 32 1585 1589 O
unknown 33 40 1590 1597 O
potential 41 50 1598 1607 O
for 51 54 1608 1611 O
abortifacient 55 68 1612 1625 O
effects 69 76 1626 1633 O

MRI 0 3 1634 1637 B-treatment
with 4 8 1638 1642 O
diffuse 9 16 1643 1650 O
abnormalities 17 30 1651 1664 O
or 31 33 1665 1667 O
1 34 35 1668 1669 O
focal 36 41 1670 1675 O
lesion 42 48 1676 1682 O

Major 0 5 1683 1688 B-treatment
surgery 6 13 1689 1696 I-treatment
within 14 20 1697 1703 O
1 21 22 1704 1705 B-upper_bound
month 23 28 1706 1711 I-upper_bound
prior 29 34 1712 1717 I-upper_bound
to 35 37 1718 1720 O
enrollment 38 48 1721 1731 O

Measurable 0 10 1732 1742 O
disease 11 18 1743 1750 O
within 19 25 1751 1757 O
the 26 29 1758 1761 O
past 30 34 1762 1766 B-upper_bound
4 35 36 1767 1768 I-upper_bound
weeks 37 42 1769 1774 I-upper_bound

PET 0 3 1775 1778 B-clinical_variable
- 3 4 1778 1779 I-clinical_variable
CT 4 6 1779 1781 I-clinical_variable
with 7 11 1782 1786 O
focal 12 17 1787 1792 O
lesion 18 24 1793 1799 O
with 25 29 1800 1804 O
increased 30 39 1805 1814 O
uptake 40 46 1815 1821 O
without 47 54 1822 1829 O
underlying 55 65 1830 1840 O
osteolytic 66 76 1841 1851 O
bone 77 81 1852 1856 O
destruction 82 93 1857 1868 O

Patients 0 8 1869 1877 O
must 9 13 1878 1882 O
have 14 18 1883 1887 O
histologically 19 33 1888 1902 O
or 34 36 1903 1905 O
cytologically 37 50 1906 1919 O
confirmed 51 60 1920 1929 O
Smoldering 61 71 1930 1940 B-cancer
Multiple 72 80 1941 1949 I-cancer
Myeloma 81 88 1950 1957 I-cancer
confirmed 89 98 1958 1967 O
by 99 101 1968 1970 O
the 102 105 1971 1974 O
Laboratory 106 116 1975 1985 O
of 117 119 1986 1988 O
Pathology 120 129 1989 1998 O
, 129 130 1998 1999 O
NCI 131 134 2000 2003 O
or 135 137 2004 2006 O
the 138 141 2007 2010 O
Department 142 152 2011 2021 O
of 153 155 2022 2024 O
Laboratory 156 166 2025 2035 O
Medicine 167 175 2036 2044 O
, 175 176 2044 2045 O
CC 177 179 2046 2048 O
based 180 185 2049 2054 O
on 186 188 2055 2057 O
the 189 192 2058 2061 O
International 193 206 2062 2075 O
Myeloma 207 214 2076 2083 O
Working 215 222 2084 2091 O
Group 223 228 2092 2097 O
Criteria 229 237 2098 2106 O

Patients 0 8 2107 2115 O
who 9 12 2116 2119 O
are 13 16 2120 2123 O
receiving 17 26 2124 2133 O
any 27 30 2134 2137 O
other 31 36 2138 2143 O
investigational 37 52 2144 2159 B-treatment
agents 53 59 2160 2166 I-treatment

Patients 0 8 2167 2175 O
with 9 13 2176 2180 O
a 14 15 2181 2182 O
diagnosis 16 25 2183 2192 O
of 26 28 2193 2195 O
MM 29 31 2196 2198 B-cancer
as 32 34 2199 2201 O
defined 35 42 2202 2209 O
by 43 45 2210 2212 O
the 46 49 2213 2216 O
2014 50 54 2217 2221 O
IMWH 55 59 2222 2226 O
diagnostic 60 70 2227 2237 O
criteria 71 79 2238 2246 O

Pregnant 0 8 2247 2255 B-pregnancy

Pregnant 0 8 2256 2264 B-pregnancy
women 9 14 2265 2270 B-gender
are 15 18 2271 2274 O
excluded 19 27 2275 2283 O
from 28 32 2284 2288 O
this 33 37 2289 2293 O
study 38 43 2294 2299 O

Progressive 0 11 2300 2311 O
increase 12 20 2312 2320 O
in 21 23 2321 2323 O
M 24 25 2324 2325 B-clinical_variable
protein 26 33 2326 2333 I-clinical_variable
level 34 39 2334 2339 I-clinical_variable
( 40 41 2340 2341 O
evolving 41 49 2341 2349 O
type 50 54 2350 2354 O
of 55 57 2355 2357 O
SMM 58 61 2358 2361 B-cancer
; 61 62 2361 2362 O
increase 63 71 2363 2371 O
in 72 74 2372 2374 O
serum 75 80 2375 2380 B-clinical_variable
M 81 82 2381 2382 I-clinical_variable
protein 83 90 2383 2390 I-clinical_variable
by 91 93 2391 2393 O
greater 94 101 2394 2401 O
than 102 106 2402 2406 O
or 107 109 2407 2409 O
equal 110 115 2410 2415 O
to 116 118 2416 2418 O
25 119 121 2419 2421 B-lower_bound
% 121 122 2421 2422 I-lower_bound
on 123 125 2423 2425 O
2 126 127 2426 2427 O
successive 128 138 2428 2438 O
evaluations 139 150 2439 2450 O
within 151 157 2451 2457 O
a 158 159 2458 2459 O
6 160 161 2460 2461 B-upper_bound
- 161 162 2461 2462 I-upper_bound
month 162 167 2462 2467 I-upper_bound
period 168 174 2468 2474 O
) 174 175 2474 2475 O

Serum 0 5 2476 2481 B-clinical_variable
M 6 7 2482 2483 I-clinical_variable
protein 8 15 2484 2491 I-clinical_variable
greater 16 23 2492 2499 O
than 24 28 2500 2504 O
or 29 31 2505 2507 O
equal 32 37 2508 2513 O
to 38 40 2514 2516 O
30g 41 44 2517 2520 B-lower_bound
/ 44 45 2520 2521 I-lower_bound
L 45 46 2521 2522 I-lower_bound

Serum 0 5 2523 2528 B-clinical_variable
M 6 7 2529 2530 I-clinical_variable
- 7 8 2530 2531 I-clinical_variable
protein 8 15 2531 2538 I-clinical_variable
greater 16 23 2539 2546 O
than 24 28 2547 2551 O
or 29 31 2552 2554 O
equal 32 37 2555 2560 O
to 38 40 2561 2563 O
3 41 42 2564 2565 B-lower_bound
g 43 44 2566 2567 I-lower_bound
/ 44 45 2567 2568 I-lower_bound
dl 45 47 2568 2570 I-lower_bound
and/or 48 54 2571 2577 O
bone 55 59 2578 2582 B-clinical_variable
marrow 60 66 2583 2589 I-clinical_variable
plasma 67 73 2590 2596 I-clinical_variable
cells 74 79 2597 2602 I-clinical_variable
greater 80 87 2603 2610 O
than 88 92 2611 2615 O
or 93 95 2616 2618 O
equal 96 101 2619 2624 O
10 102 104 2625 2627 B-lower_bound
% 104 105 2627 2628 I-lower_bound
and 106 109 2629 2632 O
< 110 111 2633 2634 O
60 111 113 2634 2636 B-upper_bound
% 113 114 2636 2637 I-upper_bound

Serum 0 5 2638 2643 B-clinical_variable
immunoglobulin 6 20 2644 2658 I-clinical_variable
free 21 25 2659 2663 I-clinical_variable
light 26 31 2664 2669 I-clinical_variable
chain 32 37 2670 2675 I-clinical_variable
> 38 39 2676 2677 O
10 39 41 2677 2679 B-lower_bound
mg 42 44 2680 2682 I-lower_bound
/ 44 45 2682 2683 I-lower_bound
dL 45 47 2683 2685 I-lower_bound

Serum 0 5 2686 2691 B-treatment
involved 6 14 2692 2700 O
/ 14 15 2700 2701 O
uninvolved 15 25 2701 2711 O
FLC 26 29 2712 2715 B-clinical_variable
ratio 30 35 2716 2721 I-clinical_variable
greater 36 43 2722 2729 O
than 44 48 2730 2734 O
or 49 51 2735 2737 O
equal 52 57 2738 2743 O
to 58 60 2744 2746 O
8 61 62 2747 2748 B-lower_bound
( 63 64 2749 2750 O
but 64 67 2750 2753 O
less 68 72 2754 2758 O
than 73 77 2759 2763 O
100 78 81 2764 2767 B-upper_bound
) 81 82 2767 2768 O

Serum 0 5 2769 2774 B-clinical_variable
monoclonal 6 16 2775 2785 I-clinical_variable
protein 17 24 2786 2793 I-clinical_variable
greater 25 32 2794 2801 O
than 33 37 2802 2806 O
or 38 40 2807 2809 O
equal 41 46 2810 2815 O
to 47 49 2816 2818 O
1.0 50 53 2819 2822 B-lower_bound
g 54 55 2823 2824 I-lower_bound
/ 55 56 2824 2825 I-lower_bound
dl 56 58 2825 2827 I-lower_bound

Significant 0 11 2828 2839 O
cardiovascular 12 26 2840 2854 B-chronic_disease
disease 27 34 2855 2862 I-chronic_disease
with 35 39 2863 2867 O
NYHA 40 44 2868 2872 B-clinical_variable
Class 45 50 2873 2878 B-lower_bound
II 51 53 2879 2881 I-lower_bound
, 53 54 2881 2882 O
III 55 58 2883 2886 O
or 59 61 2887 2889 O
IV 62 64 2890 2892 B-upper_bound
symptoms 65 73 2893 2901 O
, 73 74 2901 2902 O
or 75 77 2903 2905 O
hypertrophic 78 90 2906 2918 B-chronic_disease
cardiomegaly 91 103 2919 2931 I-chronic_disease
, 103 104 2931 2932 O
or 105 107 2933 2935 O
restrictive 108 119 2936 2947 B-chronic_disease
cardiomegaly 120 132 2948 2960 I-chronic_disease
, 132 133 2960 2961 O
or 134 136 2962 2964 O
myocardial 137 147 2965 2975 B-chronic_disease
infarction 148 158 2976 2986 I-chronic_disease

Significant 0 11 2987 2998 O
neuropathy 12 22 2999 3009 B-clinical_variable
> 23 24 3010 3011 O
Grade 24 29 3011 3016 B-lower_bound
2 30 31 3017 3018 I-lower_bound
at 32 34 3019 3021 O
the 35 38 3022 3025 O
time 39 43 3026 3030 O
of 44 46 3031 3033 O
first 47 52 3034 3039 O
dose 53 57 3040 3044 O

The 0 3 3045 3048 O
effects 4 11 3049 3056 O
of 12 14 3057 3059 O
carfilzomib 15 26 3060 3071 B-treatment
on 27 29 3072 3074 O
a 30 31 3075 3076 O
developing 32 42 3077 3087 O
human 43 48 3088 3093 O
fetus 49 54 3094 3099 O
are 55 58 3100 3103 O
unknown 59 66 3104 3111 O

The 0 3 3112 3115 O
measured 4 12 3116 3124 O
CrCl 13 17 3125 3129 B-clinical_variable
must 18 22 3130 3134 O
also 23 27 3135 3139 O
be 28 30 3140 3142 O
greater 31 38 3143 3150 O
than 39 43 3151 3155 O
or 44 46 3156 3158 O
equal 47 52 3159 3164 O
to 53 55 3165 3167 O
60 56 58 3168 3170 B-lower_bound
ml 59 61 3171 3173 I-lower_bound
/ 61 62 3173 3174 I-lower_bound
min 62 65 3174 3177 I-lower_bound

Treatment 0 9 3178 3187 B-treatment
with 10 14 3188 3192 I-treatment
corticosteroids 15 30 3193 3208 I-treatment
for 31 34 3209 3212 O
other 35 40 3213 3218 O
indications 41 52 3219 3230 O
is 53 55 3231 3233 O
permitted 56 65 3234 3243 O

Uncontrolled 0 12 3244 3256 B-chronic_disease
hypertension 13 25 3257 3269 I-chronic_disease
or 26 28 3270 3272 O
diabetes 29 37 3273 3281 B-chronic_disease

Uncontrolled 0 12 3282 3294 O
intercurrent 13 25 3295 3307 B-chronic_disease
illness 26 33 3308 3315 I-chronic_disease
including 34 43 3316 3325 O
, 43 44 3325 3326 O
but 45 48 3327 3330 O
not 49 52 3331 3334 O
limited 53 60 3335 3342 O
to 61 63 3343 3345 O
, 63 64 3345 3346 O
ongoing 65 72 3347 3354 O
or 73 75 3355 3357 O
active 76 82 3358 3364 B-chronic_disease
infection 83 92 3365 3374 I-chronic_disease
, 92 93 3374 3375 O
symptomatic 94 105 3376 3387 O
congestive 106 116 3388 3398 B-chronic_disease
heart 117 122 3399 3404 I-chronic_disease
failure 123 130 3405 3412 I-chronic_disease
, 130 131 3412 3413 O
unstable 132 140 3414 3422 B-chronic_disease
angina 141 147 3423 3429 I-chronic_disease
pectoris 148 156 3430 3438 O
, 156 157 3438 3439 O
cardiac 158 165 3440 3447 B-chronic_disease
arrhythmia 166 176 3448 3458 I-chronic_disease
, 176 177 3458 3459 O
or 178 180 3460 3462 O
psychiatric 181 192 3463 3474 B-chronic_disease
illness 193 200 3475 3482 I-chronic_disease
/ 200 201 3482 3483 O
social 201 207 3483 3489 O
situations 208 218 3490 3500 O

Urine 0 5 3501 3506 B-clinical_variable
monoclonal 6 16 3507 3517 I-clinical_variable
protein 17 24 3518 3525 I-clinical_variable
> 25 26 3526 3527 O
200 26 29 3527 3530 B-lower_bound
mg/24 30 35 3531 3536 I-lower_bound
hour 36 40 3537 3541 I-lower_bound

abnormal 0 8 3542 3550 B-clinical_variable
kappa 9 14 3551 3556 I-clinical_variable
/ 14 15 3556 3557 I-clinical_variable
lambda 15 21 3557 3563 I-clinical_variable
ratio 22 27 3564 3569 I-clinical_variable

absolute 0 8 3570 3578 B-clinical_variable
neutrophil 9 19 3579 3589 I-clinical_variable
count 20 25 3590 3595 I-clinical_variable
( 26 27 3596 3597 I-clinical_variable
ANC 27 30 3597 3600 I-clinical_variable
) 30 31 3600 3601 I-clinical_variable
greater 32 39 3602 3609 O
than 40 44 3610 3614 O
or 45 47 3615 3617 O
equal 48 53 3618 3623 O
to1.0 54 59 3624 3629 O
K 60 61 3630 3631 I-lower_bound
/ 61 62 3631 3632 I-lower_bound
uL 62 64 3632 3634 I-lower_bound

greater 0 7 3635 3642 O
than 8 12 3643 3647 O
or 13 15 3648 3650 O
equal 16 21 3651 3656 O
to 22 24 3657 3659 O
10 25 27 3660 3662 B-lower_bound
% 27 28 3662 3663 I-lower_bound

hemoglobin 0 10 3664 3674 B-clinical_variable
greater 11 18 3675 3682 O
than 19 23 3683 3687 O
or 24 26 3688 3690 O
equal 27 32 3691 3696 O
to 33 35 3697 3699 O
8 36 37 3700 3701 B-lower_bound
g 38 39 3702 3703 I-lower_bound
/ 39 40 3703 3704 I-lower_bound
dL(transfusions 40 55 3704 3719 I-lower_bound
are 56 59 3720 3723 O
permissible 60 71 3724 3735 O
) 71 72 3735 3736 O

lactating 0 9 3737 3746 O
females 10 17 3747 3754 B-gender

patients 0 8 3755 3763 O
< 9 10 3764 3765 O
18 10 12 3765 3767 B-upper_bound
years 13 18 3768 3773 I-upper_bound
of 19 21 3774 3776 O
age 22 25 3777 3780 B-age

patients 0 8 3781 3789 O
must 9 13 3790 3794 O
also 14 18 3795 3799 O
be 19 21 3800 3802 O
classified 22 32 3803 3813 O
as 33 35 3814 3816 O
high 36 40 3817 3821 O
- 40 41 3821 3822 O
risk 41 45 3822 3826 O
SMM 46 49 3827 3830 B-cancer
per 50 53 3831 3834 O
Mayo 54 58 3835 3839 O
Clinic 59 65 3840 3846 O
or 66 68 3847 3849 O
Spanish 69 76 3850 3857 O
PETHEMA 77 84 3858 3865 O
criteria 85 93 3866 3874 O

patients 0 8 3875 3883 O
with 9 13 3884 3888 O
a 14 15 3889 3890 O
baseline 16 24 3891 3899 B-clinical_variable
neutropenia 25 36 3900 3911 I-clinical_variable
that 37 41 3912 3916 O
is 42 44 3917 3919 O
chronic 45 52 3920 3927 O
and 53 56 3928 3931 O
that 57 61 3932 3936 O
does 62 66 3937 3941 O
not 67 70 3942 3945 O
cause 71 76 3946 3951 O
complications 77 90 3952 3965 O

patients 0 8 3966 3974 O
without 9 16 3975 3982 O
measurable 17 27 3983 3993 O
disease 28 35 3994 4001 O
( 36 37 4002 4003 O
e.g. 37 41 4003 4007 O
, 41 42 4007 4008 O
M 43 44 4009 4010 B-clinical_variable
- 44 45 4010 4011 I-clinical_variable
spike 45 50 4011 4016 I-clinical_variable
< 51 52 4017 4018 O
1 52 53 4018 4019 B-upper_bound
) 53 54 4019 4020 O
may 55 58 4021 4024 O
also 59 63 4025 4029 O
be 64 66 4030 4032 O
enrolled 67 75 4033 4041 O

platelets 0 9 4042 4051 B-clinical_variable
greater 10 17 4052 4059 O
than 18 22 4060 4064 O
or 23 25 4065 4067 O
equal 26 31 4068 4073 O
to75 32 36 4074 4078 O
K 37 38 4079 4080 I-lower_bound
/ 38 39 4080 4081 I-lower_bound
uL 39 41 4081 4083 I-lower_bound

reduction 0 9 4084 4093 O
of 10 12 4094 4096 O
greater 13 20 4097 4104 O
than 21 25 4105 4109 O
or 26 28 4110 4112 O
equal 29 34 4113 4118 O
to 35 37 4119 4121 O
1 38 39 4122 4123 B-lower_bound
uninvolved 40 50 4124 4134 O
immunoglobulin 51 65 4135 4149 B-clinical_variable
isotypes 66 74 4150 4158 I-clinical_variable

serum 0 5 4159 4164 B-clinical_variable
creatinine 6 16 4165 4175 I-clinical_variable
< 17 18 4176 4177 O
2.0 19 22 4178 4181 B-upper_bound
mg 23 25 4182 4184 I-upper_bound
/ 25 26 4184 4185 I-upper_bound
dL 26 28 4185 4187 I-upper_bound

total 0 5 4188 4193 O
bilirubin 6 15 4194 4203 B-clinical_variable
less 16 20 4204 4208 O
than 21 25 4209 4213 O
or 26 28 4214 4216 O
equal 29 34 4217 4222 O
to 35 37 4223 4225 O
1.5 38 41 4226 4229 B-upper_bound
times 42 47 4230 4235 I-upper_bound
institutional 48 61 4236 4249 B-clinical_variable
upper 62 67 4250 4255 I-clinical_variable
limit 68 73 4256 4261 I-clinical_variable
of 74 76 4262 4264 I-clinical_variable
normal 77 83 4265 4271 I-clinical_variable

unstable 0 8 4272 4280 B-chronic_disease
angina 9 15 4281 4287 I-chronic_disease
, 15 16 4287 4288 O
or 17 19 4289 4291 O
unstable 20 28 4292 4300 B-chronic_disease
arrhythmia 29 39 4301 4311 I-chronic_disease

within 0 6 4312 4318 O
14 7 9 4319 4321 B-upper_bound
days 10 14 4322 4326 I-upper_bound
of 15 17 4327 4329 O
enrollment 18 28 4330 4340 O

within 0 6 4341 4347 O
2 7 8 4348 4349 B-upper_bound
weeks 9 14 4350 4355 I-upper_bound
that 15 19 4356 4360 O
would 20 25 4361 4366 O
limit 26 31 4367 4372 O
compliance 32 42 4373 4383 O
with 43 47 4384 4388 O
study 48 53 4389 4394 O
requirement 54 65 4395 4406 O

within 0 6 4407 4413 O
3 7 8 4414 4415 B-upper_bound
months 9 15 4416 4422 I-upper_bound
prior 16 21 4423 4428 I-upper_bound
to 22 24 4429 4431 O
enrollment 25 35 4432 4442 O

